Q1 2023

Filed May 9, 2023 · 10-Q · 39 days after period end · 0000877860-23-000066

Q1 2023 · 10-Q

Revenue

$11.70M

— vs Q1 2022

Net Income

$34.48M

+310.6% vs Q1 2022

EPS Diluted

$0.79

+338.9% vs Q1 2022

Operating Cash Flow$31,048,000−19.7%

Margins · derived

Same quarter

Metric	Q1 2023	Q1 2022	Q1 2021	Q1 2020
Revenue	$11.70M	$0.00	$80.89M	$83.08M
Net Income	$34.48M	$8.40M	$35.33M	$61.02M
EPS Diluted	$0.79	$0.18	$0.78	$1.37

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR